• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

This product is currently not available for purchase.

RELATED PRODUCTS

Prescribing Influences: Allergic Rhinitis - Treatment tolerability remains a key differentiator Product Image

Prescribing Influences: Allergic Rhinitis - Treatment tolerability remains a key differentiator

  • ID: 1865882
  • July 2011
  • 57 pages
  • Datamonitor

Introduction

Many of the top challenges in allergic rhinitis are linked to the need for disease-modifying treatment, making this need stand out. Among symptomatic treatments, over-the-counter availability plays a key role in both patient behavior and marketing decisions, and with treatments considered mildly differentiable in terms of efficacy and safety, tolerability is a key prescribing influence.

Features and benefits

- Access The primary research of 149 pulmonologists, ENT specialists, and allergy specialists in the seven major markets
- Review the driving forces behind allergic rhinitis prescribing behavior, and where they can be influenced
- Evaluate the drug attributes that have the strongest prescribing influence in allergic rhinitis
- Assess current use of immunotherapy, and its restrictions

Highlights

DTC advertising is a key method of marketing in allergic rhinitis. Allegra’s January 2011 OTC approval was followed by a significant marketing push with considerable DTC advertising. In the nasal steroid class, companies provide physicians with samples, allowing patients to test the tolerability of the products before paying READ MORE >

Executive Summary
Strategic scoping and focus
Datamonitor key findings
Related reports
OVERVIEW
Catalyst
Summary
UNMET NEEDS
Suboptimal therapy
Disease-modifying treatment
Uncontrolled disease
Patient behavior
PRESCRIBING INFLUENCES
Treatment guidelines
Antihistamines
Leukotriene receptor antagonists
Corticosteroids
Intranasal chromones
Decongestants
Intraocular treatments
Immunotherapy
Patient acquisition process
Introduction
Patient care path
Points of influence in the patient care path
Trends in marketing strategies
Sponsorship/disease awareness campaigns
Direct-to-consumer advertising
Factors influencing physician decision making
Efficacy
Side-effect profile
Disease modification
Treatment of multiple symptoms
Cost/reimbursement status
Reimbursement
US formulary tier status for leading brands
BIBLIOGRAPHY
Journal papers
Websites
APPENDIX A
Primary research methodology
Physician sample breakdown
The survey questionnaire
APPENDIX B
Contributing experts
Conferences attended
Report methodology

Note: Product cover images may vary from those shown

Our Clients

Our clients' logos